Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Assets (2020 - 2025)

NeuroPace has reported Assets over the past 6 years, most recently at $105.6 million for Q4 2025.

  • Quarterly results put Assets at $105.6 million for Q4 2025, up 11.54% from a year ago — trailing twelve months through Dec 2025 was $105.6 million (up 11.54% YoY), and the annual figure for FY2025 was $105.6 million, up 11.54%.
  • Assets for Q4 2025 was $105.6 million at NeuroPace, down from $107.3 million in the prior quarter.
  • Over the last five years, Assets for NPCE hit a ceiling of $147.0 million in Q2 2021 and a floor of $50.3 million in Q1 2021.
  • Median Assets over the past 5 years was $106.8 million (2023), compared with a mean of $109.2 million.
  • Peak annual rise in Assets hit 156.3% in 2022, while the deepest fall reached 19.34% in 2022.
  • NeuroPace's Assets stood at $133.6 million in 2021, then fell by 14.57% to $114.1 million in 2022, then dropped by 5.66% to $107.7 million in 2023, then dropped by 12.08% to $94.6 million in 2024, then rose by 11.54% to $105.6 million in 2025.
  • The last three reported values for Assets were $105.6 million (Q4 2025), $107.3 million (Q3 2025), and $106.1 million (Q2 2025) per Business Quant data.